---
title: FDA今天批准了Moderna的RSV疫苗用于60岁以上人群接种。这是第三个被批准的RSV疫苗。其在NEJM发表的临床试验结果显示其有效性为83.7%（网页链接）；但其持久性可...
date: '2024-05-31'
linkTitle: https://weibo.com/1251560221/OgUNj77qU
source: 子陵在听歌的微博
description: 'FDA今天批准了Moderna的RSV疫苗用于60岁以上人群接种。这是第三个被批准的RSV疫苗。其在NEJM发表的临床试验结果显示其有效性为83.7%（<a
  href="https://weibo.com/1251560221/4978869512177358" data-hide=""><span class="url-icon"><img
  style="width: 1rem;height: 1rem" src="https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_small_web_default.png"
  referrerpolicy="no-referrer"></span><span class="surl-text">网页链接</span></a>）；但其持久性可能比GSK
  RSV疫苗略低（<a href="https://weibo.com/1251560221/5009921873807131" data-hide=""><span
  class="url-icon"><img style="width: 1rem;height: 1rem" src="https://h5.sinaimg.cn
  ...'
disable_comments: true
---
FDA今天批准了Moderna的RSV疫苗用于60岁以上人群接种。这是第三个被批准的RSV疫苗。其在NEJM发表的临床试验结果显示其有效性为83.7%（<a href="https://weibo.com/1251560221/4978869512177358" data-hide=""><span class="url-icon"><img style="width: 1rem;height: 1rem" src="https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_small_web_default.png" referrerpolicy="no-referrer"></span><span class="surl-text">网页链接</span></a>）；但其持久性可能比GSK RSV疫苗略低（<a href="https://weibo.com/1251560221/5009921873807131" data-hide=""><span class="url-icon"><img style="width: 1rem;height: 1rem" src="https://h5.sinaimg.cn ...